Novavax: Deal agreed to manufacture 60m doses in UK

Roger Connor, president of GSK vaccines, said: “GSK is delighted to support Novavax and the UK Vaccines Taskforce with this manufacturing arrangement for the UK and our Barnard Castle facility is now undertaking the rapid preparation work required to manufacture up to 60 million doses of this vaccine.

More Stories
Donald Trump to return to social media with ‘own platform’ in next few months, aide claims